Personnel
Management
R. Keith Frank, Ph.D.
Dr. Frank is a co-founder of IsoTherapeutics. A synthetic organic chemist by training, he has spent the first 23 years of his career at The Dow Chemical Company. His principle activity was in the development of radiopharmaceuticals, including two approved products (Quadramet® and I-125 IotrexTM). He holds 22 US patents and has over 30 publications.
Dr. Frank initiated and led ChelaMedSM radiopharmaceutical services at Dow. In that role he helped other companies develop radiopharmaceuticals and taught them about isotopes and conjugation chemistry. He also has expertise in developing tumors in animal studies and in radiation dosimetry.
Jaime (Jim) Simón, Ph.D.
Dr. Simón is a co-founder of IsoTherapeutics. He is a radiochemist by training and spent 25 years at The Dow Chemical Company where he was responsible for a group dedicated to developing new pharmaceutical technologies. He holds over 50 US patents, including the key patents covering Quadramet® (153Sm-EDTMP) for the treatment of bone cancer and STR (166Ho-DOTMP) for safely ablating bone marrow prior to bone marrow transplants. Dr Simón has over 70 publications.
Lance Cooper
Shannon L. Phillips, Ph.D.
Staff
Stephen Davis
Quality Control Manager and Human Resources Director
Tara Rumsey, B.S., MB(ASCP)cm
Technologist
George M. St. George, Ph.D.
Senior Scientist and Quality Assurance Manager
Scot Ellebracht
Chemist
Rhonda Key
Receptionist
Natalie Jennings
Quality Associate
Jacob L. Gonzales
Technologist
Tim Jones
Technologist
Shannon Gonzales, CG(ASCP)cm
Technologist and IACUC Chairman
Kim Miller
Executive Assistant and Purchasing Manager
Board of Directors
Keith Frank
Jim Simón
Lonnie Key
